If the market gets told over and over again by independent experts that PIQ products are working then we can be sure that eventually, those products will become a mainstream tool to predict future diseases.
And the share price will have to mirror this huge change in the medical practice of how to eveluate patients with those diseases.
Ann: PromarkerD clinical assay performance results published, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
-0.015(4.41%) |
Mkt cap ! $53.14M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.5¢ | $72.42K | 217.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19025 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 53089 | 4 |
View Market Depth
| Last trade - 14.27pm 24/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |